Amgen Inc. Operating Cash Flow
Amgen Inc. (AMGN) reported Operating Cash Flow of $6.19 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Amgen Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $4.00B, a 75.53% increase year-over-year.
- Amgen Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $2.19B, a 57.37% increase year-over-year.
- Amgen Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $1.60B, a 66.40% decline year-over-year.
- Amgen Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $4.68B, a 31.17% increase year-over-year.
- Amgen Inc. net cash provided by (used in) operating activities for fiscal 2025 was $9.96B, a 13.33% decline from fiscal 2024.
- Amgen Inc. net cash provided by (used in) operating activities for fiscal 2024 was $11.49B, a 35.64% increase from fiscal 2023.
- Amgen Inc. net cash provided by (used in) operating activities for fiscal 2023 was $8.47B, a 12.86% decline from fiscal 2022.
- Amgen Inc. net cash provided by (used in) operating activities for fiscal 2022 was $9.72B, a 4.97% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.19B 10-Q · filed 2026-08-05 | $7.79B derived: sum of 3 quarters · filed 2026-08-05 | $12.48B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.19B 10-Q · filed 2026-05-01 | $3.79B derived: sum of 2 quarters · filed 2026-05-01 | $8.48B derived: sum of 3 quarters · filed 2026-05-01 | $10.76B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $1.60B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.29B derived: sum of 2 quarters · filed 2026-02-13 | $8.57B derived: sum of 3 quarters · filed 2026-08-05 | $9.96B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $4.68B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.96B derived: sum of 2 quarters · filed 2026-08-05 | $8.36B 10-Q · filed 2025-11-05 | $13.13B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $2.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.67B 10-Q · filed 2026-08-05 | $8.44B derived: sum of 3 quarters · filed 2026-08-05 | $12.01B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $1.39B 10-Q · filed 2026-05-01 | $6.16B derived: sum of 2 quarters · filed 2026-05-01 | $9.73B derived: sum of 3 quarters · filed 2026-05-01 | $12.19B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $4.77B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $8.34B derived: sum of 2 quarters · filed 2026-02-13 | $10.80B derived: sum of 3 quarters · filed 2026-02-13 | $11.49B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $3.57B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.03B derived: sum of 2 quarters · filed 2025-11-05 | $6.72B 10-Q · filed 2025-11-05 | $7.26B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $2.46B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.15B 10-Q · filed 2025-08-06 | $3.69B derived: sum of 3 quarters · filed 2026-02-13 | $6.45B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $689.00M 10-Q · filed 2025-05-02 | $1.23B derived: sum of 2 quarters · filed 2026-02-13 | $3.99B derived: sum of 3 quarters · filed 2026-02-13 | $8.10B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $538.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.30B derived: sum of 2 quarters · filed 2026-02-13 | $7.41B derived: sum of 3 quarters · filed 2026-02-13 | $8.47B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $2.76B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $6.87B derived: sum of 2 quarters · filed 2024-10-31 | $7.93B 10-Q · filed 2024-10-31 | $10.58B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $4.11B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.17B 10-Q · filed 2024-08-07 | $7.82B derived: sum of 3 quarters · filed 2025-02-14 | $10.80B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $1.06B 10-Q · filed 2024-05-03 | $3.71B derived: sum of 2 quarters · filed 2025-02-14 | $6.69B derived: sum of 3 quarters · filed 2025-02-14 | $8.62B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $2.65B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $5.63B derived: sum of 2 quarters · filed 2025-02-14 | $7.56B derived: sum of 3 quarters · filed 2025-02-14 | $9.72B 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $2.98B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $4.91B derived: sum of 2 quarters · filed 2023-10-31 | $7.07B 10-Q · filed 2023-10-31 | $9.88B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $1.93B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $4.09B 10-Q · filed 2023-08-04 | $6.90B derived: sum of 3 quarters · filed 2024-02-14 | $9.32B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $2.16B 10-Q · filed 2023-04-28 | $4.97B derived: sum of 2 quarters · filed 2024-02-14 | $7.39B derived: sum of 3 quarters · filed 2024-02-14 | $9.32B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $2.81B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $5.23B derived: sum of 2 quarters · filed 2024-02-14 | $7.16B derived: sum of 3 quarters · filed 2024-02-14 | $9.26B 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $2.42B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $4.35B derived: sum of 2 quarters · filed 2022-11-04 | $6.45B 10-Q · filed 2022-11-04 | $8.61B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $1.93B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.04B 10-Q · filed 2022-08-05 | $6.19B derived: sum of 3 quarters · filed 2023-02-09 | $9.56B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $2.10B 10-Q · filed 2022-04-28 | $4.26B derived: sum of 2 quarters · filed 2023-02-09 | $7.63B derived: sum of 3 quarters · filed 2023-02-09 | $10.47B derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $2.15B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $5.52B derived: sum of 2 quarters · filed 2023-02-09 | $8.36B derived: sum of 3 quarters · filed 2023-02-09 | $10.50B 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $3.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $6.21B derived: sum of 2 quarters · filed 2021-11-03 | $8.34B 10-Q · filed 2021-11-03 | $10.86B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $2.84B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $4.98B 10-Q · filed 2021-08-04 | $7.49B derived: sum of 3 quarters · filed 2022-02-16 | $10.87B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $2.13B 10-Q · filed 2021-04-28 | $4.65B derived: sum of 2 quarters · filed 2022-02-16 | $8.03B derived: sum of 3 quarters · filed 2022-02-16 | $9.44B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $2.51B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $5.89B derived: sum of 2 quarters · filed 2022-02-16 | $7.30B derived: sum of 3 quarters · filed 2022-02-16 | $9.15B 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $3.38B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $4.79B derived: sum of 2 quarters · filed 2020-10-29 | $6.64B 10-Q · filed 2020-10-29 | $9.83B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $1.41B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $3.26B 10-Q · filed 2020-07-29 | $6.45B derived: sum of 3 quarters · filed 2021-02-09 | $9.73B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $1.84B 10-Q · filed 2020-05-01 | $5.04B derived: sum of 2 quarters · filed 2021-02-09 | $8.31B derived: sum of 3 quarters · filed 2021-02-09 | $10.41B derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $3.19B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $6.47B derived: sum of 2 quarters · filed 2021-02-09 | $8.57B derived: sum of 3 quarters · filed 2021-02-09 | $11.30B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $3.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $5.38B derived: sum of 2 quarters · filed 2019-10-30 | $8.10B 10-Q · filed 2019-10-30 | $11.11B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-06-30 | $2.10B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $4.83B 10-Q · filed 2019-07-31 | $7.84B derived: sum of 3 quarters · filed 2020-02-12 | $11.29B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-03-31 | $2.73B 10-Q · filed 2019-05-01 | $5.74B derived: sum of 2 quarters · filed 2020-02-12 | $9.19B derived: sum of 3 quarters · filed 2020-02-12 | $11.52B derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2017-12-31 | $3.01B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $6.47B derived: sum of 2 quarters · filed 2020-02-12 | $8.79B derived: sum of 3 quarters · filed 2020-02-12 | $11.18B 10-K · filed 2020-02-12 | ||||
| 2017-09-30 | $3.45B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $5.78B derived: sum of 2 quarters · filed 2018-10-31 | $8.16B 10-Q · filed 2018-10-31 | $11.27B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $2.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $4.71B 10-Q · filed 2018-07-27 | $7.81B derived: sum of 3 quarters · filed 2019-02-13 | $10.47B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $2.38B 10-Q · filed 2018-04-25 | $5.49B derived: sum of 2 quarters · filed 2019-02-13 | $8.15B derived: sum of 3 quarters · filed 2019-02-13 | $10.82B derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $3.10B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $5.76B derived: sum of 2 quarters · filed 2019-02-13 | $8.44B derived: sum of 3 quarters · filed 2019-02-13 | $10.35B 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $2.66B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $5.34B derived: sum of 2 quarters · filed 2017-10-26 | $7.25B 10-Q · filed 2017-10-26 | $9.33B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | $2.68B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $4.59B 10-Q · filed 2017-07-26 | $6.67B derived: sum of 3 quarters · filed 2018-02-13 | $9.56B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | $1.92B 10-Q · filed 2017-04-27 | $3.99B derived: sum of 2 quarters · filed 2018-02-13 | $6.88B derived: sum of 3 quarters · filed 2018-02-13 | $10.16B derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-31 | $2.07B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $4.96B derived: sum of 2 quarters · filed 2018-02-13 | $8.25B derived: sum of 3 quarters · filed 2018-02-13 | $9.73B 10-K · filed 2018-02-13 | $9.08B 10-K · filed 2016-02-16 | |||
| 2015-09-30 | $2.89B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $6.18B derived: sum of 2 quarters · filed 2016-10-28 | $7.66B 10-Q · filed 2016-10-28 | $7.02B 10-Q · filed 2015-11-02 | $10.50B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-30 | $3.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $4.77B 10-Q · filed 2016-07-29 | $4.14B 10-Q · filed 2015-08-05 | $7.61B derived: sum of 3 quarters · filed 2017-02-14 | $10.35B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-31 | $1.48B 10-Q · filed 2016-05-02 | $1.33B 10-Q · filed 2015-04-27 | $4.32B derived: sum of 2 quarters · filed 2017-02-14 | $7.07B derived: sum of 3 quarters · filed 2017-02-14 | $9.29B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-31 | $2.84B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.58B derived: sum of 2 quarters · filed 2017-02-14 | $7.81B derived: sum of 3 quarters · filed 2017-02-14 | $8.95B 10-K · filed 2017-02-14 | $8.55B 10-K · filed 2015-02-19 | |||
| 2014-09-30 | $2.74B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $4.97B derived: sum of 2 quarters · filed 2015-11-02 | $6.11B 10-Q · filed 2015-11-02 | $8.18B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-06-30 | $2.23B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.37B 10-Q · filed 2015-08-05 | $5.44B derived: sum of 3 quarters · filed 2016-10-31 | $7.25B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-03-31 | $1.14B 10-Q · filed 2015-04-27 | $3.21B derived: sum of 2 quarters · filed 2016-10-31 | $5.02B derived: sum of 3 quarters · filed 2016-10-31 | $6.62B derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2013-12-31 | $2.07B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $3.88B derived: sum of 2 quarters · filed 2016-10-31 | $5.48B derived: sum of 3 quarters · filed 2016-10-31 | $6.53B 8-K · filed 2016-10-31 | $6.29B 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $1.81B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $3.41B derived: sum of 2 quarters · filed 2014-10-29 | $4.46B 10-Q · filed 2014-10-29 | $5.27B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | $1.60B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $2.65B 10-Q · filed 2014-08-05 | $3.46B derived: sum of 3 quarters · filed 2015-02-19 | $5.18B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | $1.05B 10-Q · filed 2014-04-30 | $1.86B derived: sum of 2 quarters · filed 2015-02-19 | $3.58B derived: sum of 3 quarters · filed 2015-02-19 | $5.96B derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $812.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $2.54B derived: sum of 2 quarters · filed 2015-02-19 | $4.91B derived: sum of 3 quarters · filed 2015-02-19 | $5.88B 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $1.72B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $4.10B derived: sum of 2 quarters · filed 2013-10-29 | $5.07B 10-Q · filed 2013-10-29 | $6.65B derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-06-30 | $2.38B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $3.35B 10-Q · filed 2013-08-06 | $4.93B derived: sum of 3 quarters · filed 2014-02-24 | $5.90B derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-03-31 | $972.00M 10-Q · filed 2013-05-03 | $2.56B derived: sum of 2 quarters · filed 2014-02-24 | $3.52B derived: sum of 3 quarters · filed 2014-02-24 | $5.06B derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2011-12-31 | $1.58B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $2.55B derived: sum of 2 quarters · filed 2014-02-24 | $4.09B derived: sum of 3 quarters · filed 2014-02-24 | $5.12B 10-K · filed 2014-02-24 | ||||
| 2011-09-30 | $969.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.50B derived: sum of 2 quarters · filed 2012-11-06 | $3.54B 10-Q · filed 2012-11-06 | $5.54B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $1.54B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.57B 10-Q · filed 2012-08-08 | $4.57B derived: sum of 3 quarters · filed 2013-02-27 | $5.88B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $1.03B 10-Q · filed 2012-05-08 | $3.04B derived: sum of 2 quarters · filed 2013-02-27 | $4.34B derived: sum of 3 quarters · filed 2013-02-27 | $5.90B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $2.01B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $3.31B derived: sum of 2 quarters · filed 2013-02-27 | $4.87B derived: sum of 3 quarters · filed 2013-02-27 | $5.79B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $1.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $2.87B derived: sum of 2 quarters · filed 2011-11-04 | $3.78B 10-Q · filed 2011-11-04 | $5.60B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $1.56B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $2.48B 10-Q · filed 2011-08-08 | $4.30B derived: sum of 3 quarters · filed 2012-02-29 | $6.28B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $913.00M 10-Q · filed 2011-05-10 | $2.74B derived: sum of 2 quarters · filed 2012-02-29 | $4.71B derived: sum of 3 quarters · filed 2012-02-29 | $6.39B derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $1.82B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $3.80B derived: sum of 2 quarters · filed 2012-02-29 | $5.48B derived: sum of 3 quarters · filed 2012-02-29 | $6.34B 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $1.98B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $3.65B derived: sum of 2 quarters · filed 2010-11-08 | $4.51B 10-Q · filed 2010-11-08 | $5.91B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-30 | $1.68B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $2.54B 10-Q · filed 2010-08-09 | $3.94B derived: sum of 3 quarters · filed 2011-02-25 | $5.33B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-31 | $859.00M 10-Q · filed 2010-05-07 | $2.26B derived: sum of 2 quarters · filed 2011-02-25 | $3.65B derived: sum of 3 quarters · filed 2011-02-25 | |||||
| 2008-12-31 | $1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $2.79B derived: sum of 2 quarters · filed 2011-02-25 | $5.99B 10-K · filed 2011-02-25 | |||||
| 2008-09-30 | $1.39B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $4.59B 10-Q · filed 2009-11-06 | ||||||
| 2008-06-30 | $3.20B 10-Q · filed 2009-08-10 | |||||||
| 2007-12-31 | $5.40B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |